Sign in

CIK 0001750284

  • Non-accelerated filer
  • Smaller reporting company

Olema Oncology, Inc.

Sign in to watch
Ticker
OLMA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
300409740
Phone
+1 415-651-3316
Business address
365 OYSTER POINT BOULEVARD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
Former names
Olema Pharmaceuticals, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 3 Insider Initial Statement of Ownership
  10. 4 Open-market sale CHIEF BUSINESS OFFICER sold 5,251 shares at $6.85 ($35,969)
  11. 4 Open-market sale CHIEF BUSINESS OFFICER sold 5,251 shares at $10.39 ($54,558)
  12. 4 Open-market sale CHIEF DEVELOPMENT OFFICER sold 10,000 shares at $10.30 ($103,000)
  13. 4 Open-market buy Director bought 739,675 shares at $9.39 ($6,945,770)
  14. 4 Open-market sale CHIEF TECHNOLOGY OFFICER sold 400 shares at $24.76 ($9,904)
  15. 4 Open-market sale CHIEF BUSINESS OFFICER sold 27,668 shares at $26.88 ($743,716)
  16. 4 Open-market sale CHIEF TECHNOLOGY OFFICER sold 12,000 shares at an average $27.98 ($335,794)
  17. 4 Open-market sale PRESIDENT AND CEO sold 5,000 shares at an average $30.47 ($152,363)
  18. 4 Open-market sale CHIEF BUSINESS OFFICER sold 5,251 shares at an average $27.90 ($146,510)
  19. 4 Open-market sale PRESIDENT AND CEO sold 1,085 shares at $30.07 ($32,626)
  20. 4 Open-market sale CHIEF TECHNOLOGY OFFICER sold 12,000 shares at $26.30 ($315,600)

Page 9 of 13 · 244 filings